Try our beta test site
1 study found for:    18725648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Conditions: Breast Cancer;   Low Bone Mineral Density;   Osteopenia
Interventions: Drug: Placebo;   Drug: AMG 162 / Denosumab

Study has passed its completion date and status has not been verified in more than two years.